Arix Bioscience plc 13D/13G Filings for Autolus Therapeutics plc (AUTL)

Arix Bioscience plc 13D and 13G filings for Autolus Therapeutics plc:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Shares have been adjusted for stock splits.
Time period
Reported
DateTime
Transaction
Date
Type Company
Symbol
Filed By
Symbol
Shares Owned
% Owned
Shares Vs. Prev Report View
2021-02-17
5:01 pm
Sale
2021-02-12 13D Autolus Therapeutics plc
AUTL
Arix Bioscience plc 3,319,866
4.800%
-50,000decrease
(-1.48%)
Filing
2021-01-08
4:15 pm
Purchase
2021-01-01 13D Autolus Therapeutics plc
AUTL
Arix Bioscience plc 3,369,866
6.400%
208,333increase
(+6.59%)
Filing